Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery ...

Medtronic announced today that it selected "MiniMed" as the name for its Diabetes unit following its planned separation.

Human insulin presents Indian companies an opportunity estimated at Rs 450 crore per annum in India and $157 million/annum in emerging markets.

Prefilled pens offer convenience compared to using a syringe, and may be for those who don’t choose to wear an insulin pump device. Plastic, prefilled insulin pens are an option that makes ...

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

Manufacturers investing in patient education, customer service, and app development tend to build stronger brand loyalty. Top companies in the smart insulin pens market include both well-established ...

The Go-Pen user-filled insulin pen. [Image courtesy of Go-Pen ApS] Go-Pen ApS announced recently that it received FDA 510(k) clearance for its Go-Pen cost-effective, user-filled insulin pen.

Thirty-seven-year-old Nupur Lalvani, who has been living with Type 1 diabetes since the age of eight, was dependent on insulin pens and had of late been a regular user of Novo Nordisk’s largest ...

The phase out could further impact the pharmaceutical's top brands in the Rs 5,000 crore insulin market including Actrapid, Insulatard, Insulin Detemir and Levemir and Xultophy, which are marketed ...

The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 Billion in 2024 and an impressive US$ 3.08 Billion by ...

The global Smart Insulin Pens Market is experiencing substantial growth, driven by the increasing prevalence of diabetes, advancements in digital healthcare solutions, and the demand for user-friendly ...